Quantity size:
0.2ml
Concentration:
1mg/ml 二氢嘧啶脱氢酶抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Dihydropyrimidine dehydrogenase (DPYD) catalyzes the first rate-limiting step of the NADPH-dependent catabolism of uracil and thymine to dihydrouracil and dihydrothymine; thus, a deficiency of DPYD leads to an accumulation of uracil and thymine. Abnormal concentrations of these metabolites in bodily fluids may be the cause of neurological disease and a contraindication for treatment of cancer patients with certain pyrimidine analogs. DPYD also 二氢嘧啶脱氢酶抗体catalyzes the anticancer agent 5-fluorouracil (5-FU) pathway and is involved in the efficacy and toxicity of 5-FU. Variations in DPYD concentration may arise from alterations at the transcriptional level of the dihydropyrimidine dehydrogenase gene. Specifically, hypermethylation of the DPYD promoter downregulates dihydropyrimidine dehydrogenase expression. Deficient DPYD alleles may constitute a risk factor for severe toxicity following treatment with 5-FU. Involvement in disease:
二氢嘧啶脱氢酶抗体Defects in DPYD are the cause of dihydropyrimidine dehydrogenase deficiency (DPYD deficiency) ; also known as hereditary thymine-uraciluria or familial pyrimidinemia. DPYD deficiency is a disease characterized by persistent urinary excretion of excessive amounts of uracil, thymine and 5-hydroxymethyluracil. Patients suffering from this disease show a severe reaction to the anticancer drug 5-fluorouracil. This reaction includes stomatitis, Leukopenia, thrombocytopenia, hair loss, diarrhea, fever, marked weight loss, cerebellar ataxia, and neurologic symptoms, progressing to semicoma.
Also known as:
二氢嘧啶脱氢酶抗体DHP; DHPDHase; Dihydropyrimidine dehydrogenase [NADP+]; Dihydropyrimidine dehydrogenase; Dihydrothymine dehydrogenase; Dihydrouracil dehydrogenase; DPD; DPYD; DPYD_HUMAN; MGC132008; MGC70799; OTTHUMP00000058954.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human DPYD.
●
二氢嘧啶脱氢酶抗体Predicted Molecular Weight: 111kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl918Po01成纤维细胞生长因子21(FGF21)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 21 (FGF21)
kl919Hu01血小板衍生生长因子D(PDGFD)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor D (PDGFD)
kl920Hu01血小板衍生生长因子C(PDGFC)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor C (PDGFC)
kl920Mu01血小板衍生生长因子C(PDGFC)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor C (PDGFC)
kl921Hu01血小板衍生生长因子B(PDGFB)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor Subunit B (PDGFB)
kl921Po01血小板衍生生长因子B(PDGFB)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor Subunit B (PDGFB)
kl921Ra01血小板衍生生长因子B(PDGFB)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor Subunit B (PDGFB)
kl922Hu01血小板衍生生长因子受体样蛋白(PDGFRL)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor Receptor Like Protein (PDGFRL)
kl922Mu01血小板衍生生长因子受体样蛋白(PDGFRL)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor Receptor Like Protein (PDGFRL)
kl923Hu01生长激素2(GH2)多克隆抗体Polyclonal Antibody to Growth Hormone 2 (GH2)
kl935Ra01促肾上腺皮质素释放激素受体1(CRHR1)多克隆抗体Polyclonal Antibody to Corticotropin Releasing Hormone Receptor 1 (CRHR1)
kl937Mu01鞘氨醇1磷酸酯受体1(S1PR1)多克隆抗体Polyclonal Antibody to Sphingosine 1 Phosphate Receptor 1 (S1PR1)
kl944Hu01晶状体蛋白αB(CRYαB)多克隆抗体Polyclonal Antibody to Crystallin Alpha B (CRYaB)
kl944Mu01晶状体蛋白αB(CRYαB)多克隆抗体Polyclonal Antibody to Crystallin Alpha B (CRYaB)
kl947Hu01卵泡刺激素受体(FSHR)多克隆抗体Polyclonal Antibody to Follicle Stimulating Hormone Receptor (FSHR)
kl950Hu01大麻素受体1(CNR1)多克隆抗体Polyclonal Antibody to Cannabinoid Receptor 1, Brain (CNR1)
kl950Ra01大麻素受体1(CNR1)多克隆抗体Polyclonal Antibody to Cannabinoid Receptor 1, Brain (CNR1)
kl952Hu01窖蛋白2(CAV2)多克隆抗体Polyclonal Antibody to Caveolin 2 (CAV2)
kl960Hu01钙蛋白酶3(CAPN3)多克隆抗体Polyclonal Antibody to Calpain 3 (CAPN3)
kl964Hu01组织蛋白酶B(CTSB)多克隆抗体Polyclonal Antibody to Cathepsin B (CTSB)
kl965Hu01组织蛋白酶C(CTSC)多克隆抗体Polyclonal Antibody to Cathepsin C (CTSC)
kl969Hu01组织蛋白酶Z(CTSZ)多克隆抗体Polyclonal Antibody to Cathepsin Z (CTSZ)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话